{"id":"elcatonin","rwe":[{"pmid":"40109792","year":"2025","title":"Unmasking Latent Primary Hyperparathyroidism in Guillain-Barré Syndrome: A Case Report and Literature Review.","finding":"","journal":"Cureus","studyType":"Clinical Study"},{"pmid":"38188785","year":"2023","title":"Retracted: Impact of Alendronate Sodium plus Elcatonin on Postoperative Bone Pain in Patients with Osteoporotic Fractures.","finding":"","journal":"BioMed research international","studyType":"Clinical Study"},{"pmid":"37227595","year":"2024","title":"Granulocyte-colony stimulating factor producing cervical cancer with elevated levels of parathyroid hormone-related protein: a case report and literature review.","finding":"","journal":"CEN case reports","studyType":"Clinical Study"},{"pmid":"37001370","year":"2023","title":"A case report of effective intra-articular elcatonin administration in a patient with osteonecrosis of the lunate.","finding":"","journal":"International journal of surgery case reports","studyType":"Clinical Study"},{"pmid":"36119926","year":"2022","title":"Impact of Alendronate Sodium plus Elcatonin on Postoperative Bone Pain in Patients with Osteoporotic Fractures.","finding":"","journal":"BioMed research international","studyType":"Clinical Study"}],"tags":[{"label":"elcatonin","category":"class"},{"label":"Peptide","category":"modality"},{"label":"H05BA04","category":"atc"},{"label":"Active","category":"status"},{"label":"Calcium-Regulating Hormones and Agents","category":"pharmacology"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"elcitonin","offLabel":[],"synonyms":["elcatonin","carbicalcin","carbocalcitonin","elcitonin","turbocalcin"],"timeline":[],"approvals":[],"brandName":"Elcitonin","ecosystem":[],"mechanism":{"modality":"Peptide","drugClass":"elcatonin","explanation":"In plain English, elcatonin is a synthetic version of a natural molecule that helps regulate various bodily functions. It's like a key that fits into a lock, allowing the body to respond in a specific way. By mimicking this natural molecule, elcatonin may help restore balance to the body's systems.","oneSentence":"Elcatonin is thought to work by mimicking the action of certain natural peptides in the body.","technicalDetail":"Elcatonin is a synthetic peptide hormone that interacts with specific receptors in the body, triggering a cascade of downstream effects that may influence various physiological processes."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/994","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=ELCATONIN","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ELCATONIN","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T10:57:42.949219","biosimilars":[],"competitors":[{"drugName":"calcitonin (salmon synthetic)","drugSlug":"calcitonin-(salmon-synthetic)","fdaApproval":"1978-04-17","relationship":"same-class"},{"drugName":"calcitonin human","drugSlug":"calcitonin-human","fdaApproval":"1986-10-31","patentStatus":"Unknown","relationship":"same-class"}],"genericName":"elcatonin","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"calcitonin-(salmon-synthetic)","brandName":"calcitonin (salmon synthetic)","genericName":"calcitonin (salmon synthetic)","approvalYear":"1978","relationship":"same-class"},{"drugId":"calcitonin-human","brandName":"calcitonin human","genericName":"calcitonin human","approvalYear":"1986","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT02856347","phase":"NA","title":"Prospective Study Evaluating the Medullary Thyroid Cancer Management's Care Using PET F-DOPA in Patients With a High Level of Postoperative Residual Thyrocalcitonin","status":"COMPLETED","sponsor":"Institut Claudius Regaud","startDate":"2017-03-22","conditions":["Medullary Thyroid Cancer"],"enrollment":24,"completionDate":"2020-12-20"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"W0CMS474JK","CHEBI":"CHEBI:135916","INN_ID":"4946","UMLSCUI":"C0115656","ChEMBL_ID":"CHEMBL2104402","KEGG_DRUG":"D03287","DRUGBANK_ID":"DB13742","PUBCHEM_CID":"164512660","SNOMEDCT_US":"702803000","MESH_SUPPLEMENTAL_RECORD_UI":"C012755"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":149,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"H05BA04","allCodes":["H05BA04"]},"biosimilarFilings":[],"recentPublications":[{"date":"2025 Feb","pmid":"40109792","title":"Unmasking Latent Primary Hyperparathyroidism in Guillain-Barré Syndrome: A Case Report and Literature Review.","journal":"Cureus"},{"date":"2023","pmid":"38188785","title":"Retracted: Impact of Alendronate Sodium plus Elcatonin on Postoperative Bone Pain in Patients with Osteoporotic Fractures.","journal":"BioMed research international"},{"date":"2024 Feb","pmid":"37227595","title":"Granulocyte-colony stimulating factor producing cervical cancer with elevated levels of parathyroid hormone-related protein: a case report and literature review.","journal":"CEN case reports"},{"date":"2023 Apr","pmid":"37001370","title":"A case report of effective intra-articular elcatonin administration in a patient with osteonecrosis of the lunate.","journal":"International journal of surgery case reports"},{"date":"2022","pmid":"36119926","title":"Impact of Alendronate Sodium plus Elcatonin on Postoperative Bone Pain in Patients with Osteoporotic Fractures.","journal":"BioMed research international"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Recombinant protein","firstApprovalDate":"","aiSummary":"Elcatonin (ELCATONIN) is a small molecule drug in the elcatonin class, originally developed by an unknown entity and currently owned by an unknown entity. Its target and exact mechanism of action are unknown, and it has not been approved by the FDA for any indications. The commercial status of elcatonin is unclear, with unknown patent status and generic manufacturers. Further research is needed to determine its safety profile and potential therapeutic applications.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}